Independent Director · Avalo Therapeutics, Inc. (AVTX)

Chair, Audit Committee

Kevin Lind director compensation at Avalo Therapeutics (FY2025): $456K

Fiscal year 2025 director compensation for Kevin Lind at Avalo Therapeutics, Inc.. Every figure below is printed as the company filed it and cited to the filing it came from.

Director compensation as of the proxy filed April 10, 2026 (DEF 14A). Open the filing on EDGAR.

Free

Get Kevin Lind’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Kevin Lind and every company like it: Velarion Intel, free for 3 days, no card →

What they were paid

Avalo Therapeutics Director Compensation Table · the one fiscal year held
In US dollars, as Avalo Therapeutics reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2025$0$0$456,488—$456,488

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Avalo Therapeutics, Inc. DEF 14A filed April 10, 2026, accession 0001534120-26-000022, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Avalo Therapeutics, Inc. filed document, accession 0001534120-26-000022. Every figure is read from that document and cited to the page and table it appears in. Filed April 10, 2026.

Get the Avalo Therapeutics Board Governance Report

$456,488 Kevin Lind, FY2025 total director compensation

$500

The free page is the headline figures. The board report is director pay, board composition and committee fees combined into the same kind of document.

Data as of April 10, 2026 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).

How this board is paid

company policy · FY2025

Avalo Therapeutics pays directors a $40,000 cash retainer and $20,100 in Options.

Committees

FY2025 · as the proxy prints them

Audit (Chair) · Compensation

The rest of the Avalo Therapeutics board

FY2025 · as the company reported each
DirectorRoleFY2025 total
Aaron KantoffIndependent Director$128,973
Gilla Kaplan, Ph.DIndependent Director$126,955
Jonathan Goldman, M.DIndependent Director$128,473
Michael HeffernanChair of the Board$509,578
Mitchell ChanIndependent Director$133,991
Rita Jain, M.DIndependent Director$177,579
Samantha TruexIndependent Director$127,473

The full Avalo Therapeutics compensation record

free company brief

This page is one director within Avalo Therapeutics's record. The company brief lists every named executive and director, each linking to their own page.

Order AVTX

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Board Governance Report